Med (Baltimore) (2019) 98:e18245
doi: 10.1210/jc.2018-01176 70 KanetoHTakamiASprangerRAmanoAWatanabeDNiemoellerE
PubMed (NIH/NLM) records related to this compound for laboratory literature review
(5.6) Hypersensitivity Reactions: Anaphylactic reactions and angioedema have been reported postmarketing
JFNG has received grants from Abbvie, Bionet Medical, Boehringer Ingelheim, Sanofi-Genzyme, Shire and CSL Vifor, and consultancy or speaker fees or travel support from AstraZeneca, Amgen, Bayer, Bionet Medical, Boehringer Ingelheim, Eli Lilly, Esteve, GlaxoSmithKline, Janssen, Menarini, MSD, Mundipharma, Novartis, Novo-Nordisk, Sanofi-Genzyme, Servier and CSL Vifor
Dual GIP + GLP-1 agonist Member results A stronger next step for members who need better hunger control or fresh momentum